Evidence map›Paper›PMID 37880797›Full record

ArticleArthritis research & therapy2023

Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registry.

Marta Valero, Carlos Sanchez-Piedra, Mercedes Freire, Maria Colazo, Noemi Busquets, Erardo Merino-Ibarra, Carlos Rodriguez-Lozano, Sara Manrique, Cristina Campos, Fernando Sanchez-Alonso and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Arthritis research & therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Marta ValeroServicio de Reumatologia, Hospital Universitario Ramon Y CajalInstituto Ramon Y Cajal de Investigacion Sanitaria (IRYCIS), Carretera de Colmenar Viejo Km: 9,100, 28034, Madrid, Spain. martavaleroex@yahoo.es.
Carlos Sanchez-PiedraHealth Technology Assessment Agency of Carlos III Institute of Health (ISCIII), Madrid, Spain.
Mercedes FreireDepartment of Rheumatology, Complejo Hospitalario Universitario A Coruna, A Coruna, Spain.
Maria ColazoDepartment of Rheumatology, Hospital Universitario de Burgos, Burgos, Spain.
Noemi BusquetsDepartment of Rheumatology, Hospital General de Granollers, Granollers, Barcelona, Spain.
Erardo Merino-IbarraDepartment of Rheumatology, Hospital Universitario Miguel Servet, Saragossa, Spain.
Carlos Rodriguez-LozanoDepartment of Rheumatology, Hospital Universitario de Gran Canaria Doctor Negrin, Las Palmas de Gran Canaria, Spain.
Sara ManriqueDepartment of Rheumatology, Hospital Universitario Regional de Malaga (Hospital Carlos Haya), Malaga, Spain.
Cristina CamposDepartment of Rheumatology, Hospital General Universitario de Valencia, Valencia, Spain.
Fernando Sanchez-AlonsoResearch Unit of Spanish Society of Rheumatology, Madrid, Spain.
Isabel CastrejonDepartment of Rheumatology, Hospital General Universitario Gregorio MaranonInstituto de Investigacion Sanitaria Gregorio Maranon (IiSGM), Universidad Complutense de Madrid, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37880797
PMCPMC10598974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.